You start taking Avastin® (bevacizumab) with carboplatin and paclitaxel (chemotherapy) to treat your advanced nonsquamous non–small cell lung cancer (nsNSCLC). And you keep taking Avastin as long as your disease is controlled and your side effects are manageable.
By continuing to take Avastin, you may be able to continue to control your cancer.
There are some side effects that may require you to stop Avastin therapy. Your doctor will determine whether you should stop taking Avastin. But as long as your side effects stay manageable and your cancer is under control, you should keep taking Avastin.
Continue taking Avastin for your nsNSCLC even if:
Questions about Avastin treatment costs? Let us help you understand your financial assistance options.
Avastin is a tumor-starving therapy. Read more about how it's designed to work.
Find helpful information and support.
The information contained in this section of the site is intended for U.S. healthcare professionals only. Click "OK" if you are a healthcare professional.
The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control. Genentech does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.